104 related articles for article (PubMed ID: 8005742)
21. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
Shingleton HM; Bell MC; Fremgen A; Chmiel JS; Russell AH; Jones WB; Winchester DP; Clive RE
Cancer; 1995 Nov; 76(10 Suppl):1948-55. PubMed ID: 8634986
[TBL] [Abstract][Full Text] [Related]
22. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma.
Kristensen GB; Abeler VM; Risberg B; Trop C; Bryne M
Gynecol Oncol; 1999 Aug; 74(2):245-51. PubMed ID: 10419739
[TBL] [Abstract][Full Text] [Related]
23. Histopathologic prognostic factors in stage II and III squamous cell carcinoma of the uterine cervix. An evaluation of 91 patients treated primarily with radiation therapy.
Crissman JD; Budhraja M; Aron BS; Cummings G
Int J Gynecol Pathol; 1987; 6(2):97-103. PubMed ID: 3692673
[TBL] [Abstract][Full Text] [Related]
24. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
25. Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
Sutton GP; Blessing JA; Barrett RJ; Gallup DG
Gynecol Oncol; 1994 Feb; 52(2):229-31. PubMed ID: 8314144
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma.
Scholten AN; Smit VT; Beerman H; van Putten WL; Creutzberg CL
Cancer; 2004 Feb; 100(4):764-72. PubMed ID: 14770433
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of the cyto-histological classification of infiltrating cervical epidermoid carcinoma.
dalla Palma P; Arslan Pagnini C; de Laurentiis G
Tumori; 1980 Apr; 66(2):183-90. PubMed ID: 7445100
[TBL] [Abstract][Full Text] [Related]
28. Histopathologic prognostic factors in early stage cervical carcinoma.
Benda JA
J Natl Cancer Inst Monogr; 1996; (21):27-34. PubMed ID: 9023825
[TBL] [Abstract][Full Text] [Related]
29. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study.
Look KY; Blessing JA; Levenback C; Kohler M; Chafe W; Roman LD
Gynecol Oncol; 1998 Sep; 70(3):334-8. PubMed ID: 9790784
[TBL] [Abstract][Full Text] [Related]
30. Data Set for the Reporting of Carcinomas of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR).
McCluggage WG; Judge MJ; Alvarado-Cabrero I; Duggan MA; Horn LC; Hui P; Ordi J; Otis CN; Park KJ; Plante M; Stewart CJR; Wiredu EK; Rous B; Hirschowitz L
Int J Gynecol Pathol; 2018 May; 37(3):205-228. PubMed ID: 28700433
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
[TBL] [Abstract][Full Text] [Related]
32. Investigation of age as a prognostic factor in early stage invasive cancer of the cervix. Implications for nursing.
Kaplan M
Cancer Nurs; 1989 Jun; 12(3):177-82. PubMed ID: 2743301
[TBL] [Abstract][Full Text] [Related]
33. Cervical carcinoma with glandular differentiation: histological evaluation predicts disease recurrence in clinical stage I or II patients.
Costa MJ; McIlnay KR; Trelford J
Hum Pathol; 1995 Aug; 26(8):829-37. PubMed ID: 7635446
[TBL] [Abstract][Full Text] [Related]
34. Histologic grade and prognosis of carcinoma of the cervix.
Chung CK; Stryker JA; Ward SP; Nahhas WA; Mortel R
Obstet Gynecol; 1981 May; 57(5):636-42. PubMed ID: 7219913
[TBL] [Abstract][Full Text] [Related]
35. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Gershenson DM; McGehee R
J Clin Oncol; 1999 Sep; 17(9):2676-80. PubMed ID: 10561341
[TBL] [Abstract][Full Text] [Related]
37. Age and prognosis in stage Ib squamous cell carcinoma of the uterine cervix.
Gynning I; Johnsson JE; Alm P; Tropé C
Gynecol Oncol; 1983 Feb; 15(1):18-26. PubMed ID: 6822365
[TBL] [Abstract][Full Text] [Related]
38. Risk grouping in stage IB squamous cell cervical carcinoma.
Van de Putte G; Lie AK; Vach W; Baekelandt M; Kristensen GB
Gynecol Oncol; 2005 Oct; 99(1):106-12. PubMed ID: 16137752
[TBL] [Abstract][Full Text] [Related]
39. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Rose PG; Blessing JA; Van Le L; Waggoner S
Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
